BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25339098)

  • 1. Subclinical hypothyroidism and cardiovascular risk.
    Vayá A; Giménez C; Sarnago A; Alba A; Rubio O; Hernández-Mijares A; Cámara R
    Clin Hemorheol Microcirc; 2014; 58(1):1-7. PubMed ID: 25339098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism.
    Hueston WJ; King DE; Geesey ME
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):582-7. PubMed ID: 16268812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for cardiovascular disease in patients with subclinical hypothyroidism.
    Toruner F; Altinova AE; Karakoc A; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Adv Ther; 2008 May; 25(5):430-7. PubMed ID: 18484201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial.
    Christ-Crain M; Meier C; Guglielmetti M; Huber PR; Riesen W; Staub JJ; Müller B
    Atherosclerosis; 2003 Feb; 166(2):379-86. PubMed ID: 12535752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Selected Atherosclerosis Risk Factors in Women with Subclinical Hypothyroidism Treated with L-Thyroxine.
    Adamarczuk-Janczyszyn M; Zdrojowy-Wełna A; Rogala N; Zatońska K; Bednarek-Tupikowska G
    Adv Clin Exp Med; 2016; 25(3):457-63. PubMed ID: 27629733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study.
    McQuade C; Skugor M; Brennan DM; Hoar B; Stevenson C; Hoogwerf BJ
    Thyroid; 2011 Aug; 21(8):837-43. PubMed ID: 21745107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
    Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and other cardiovascular risk factors in patients with lichen planus.
    Saleh N; Samir N; Megahed H; Farid E
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1507-13. PubMed ID: 24330130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological, biochemical and inflammatory parameters in inactive Behçet's disease. Its association with red blood cell distribution width.
    Vayá A; Rivera L; Todolí J; Hernandez JL; Laiz B; Ricart JM
    Clin Hemorheol Microcirc; 2014; 56(4):319-24. PubMed ID: 23719420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Cardiovascular Risk Factors and Serum Thyrotropin Concentration Among Healthy Chinese Subjects and Subjects with Unsuspected Subclinical Hypothyroidism.
    Wu J; Tao Y; Gu H; Sui J
    Clin Lab; 2016; 62(5):807-14. PubMed ID: 27349005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
    Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High thyroid-stimulating hormone level is associated with the risk of developing atherosclerosis in subclinical hypothyroidism.
    Gao CX; Yang B; Guo Q; Wei LH; Tian LM
    Horm Metab Res; 2015 Mar; 47(3):220-4. PubMed ID: 25372775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of inflammatory and lipidic parameters on red blood cell distribution width in a healthy population.
    Vayá A; Sarnago A; Fuster O; Alis R; Romagnoli M
    Clin Hemorheol Microcirc; 2015; 59(4):379-85. PubMed ID: 25159489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy?
    Gursoy A; Ozduman Cin M; Kamel N; Gullu S
    Int J Clin Pract; 2006 Jun; 60(6):655-9. PubMed ID: 16805747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma viscosity, an early cardiovascular risk factor in women with subclinical hypothyroidism.
    Erdem TY; Ercan M; Ugurlu S; Balci H; Acbay O; Gundogdu S
    Clin Hemorheol Microcirc; 2008; 38(4):219-25. PubMed ID: 18334776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of fenofibrate on metabolic and cardiovascular risk factors in mixed dyslipidemic women with normal thyroid function and subclinical hypothyroidism.
    Krysiak R; Gilowski W; Szkrobka W; Okopien B
    Cardiovasc Ther; 2014 Dec; 32(6):264-9. PubMed ID: 25290818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids, tHcy, hs-CRP, MDA and PON-1 levels in SCH and overt hypothyroidism: effect of treatment.
    Singh S; Dey Sarkar P
    Acta Biomed; 2014 Aug; 85(2):127-34. PubMed ID: 25245648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults.
    Tseng FY; Lin WY; Lin CC; Lee LT; Li TC; Sung PK; Huang KC
    J Am Coll Cardiol; 2012 Aug; 60(8):730-7. PubMed ID: 22726629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.